TCT-639 Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Vessels ≤2.5 mm Diameter

Ronald Caputo; Martin B. Leon; Patrick W. Serruys; Franz‐Josef Neumann; Alan C. Yeung; Stephan Windecker; Jorge Belardi; Sigmund Silber; Ian T. Meredith; Petr Widimský; Shigeru Saito; Laura Mauri

doi:10.1016/j.jacc.2012.08.676

Related publications

Article2012

THE RESOLUTE ZOTAROLIMUS-ELUTING STENT IN PATIENTS WIH DIABETES MELLITUS: TWO YEAR OUTCOMES

Alan C. Yeung, Martin B. Leon, Sigmund Silber, Patrick W. Serruys, Stephan Windecker, Jorge Belardi, Ian T. Meredith, Franz ndash Josef Neumann, Petr Widimský, Shigeru Saito, Joseph M. Massaro, Laura Mauri

Journal of the American College of Cardiology

Article2018

TCT-137 Five-Year Clinical Outcomes for Resolute Zotarolimus-Eluting Stents in Total Occlusions

Robert W. Yeh, Henning Kelbæk, Franz‐Josef Neumann, Patrick W. Serruys, Stephan Windecker, Jorge Belardi, Bo Xu, Shubin Qiao, Minglei Liu, Sigmund Silber

Journal of the American College of Cardiology

Article2011

SIX MONTH CLINICAL OUTCOMES FOLLOWING THE IMPLANTATION OF THE BIORESORBABLE EVEROLIMUS ELUTING VASCULAR SCAFFOLD IN VESSELS SMALLER OR LARGER THAN 2.5 MM

Roberto Diletti, Yoshinobu Onuma, Vasim Farooq, Josep Gómez‐Lara, Salvatore Brugaletta, Robert‐Jan van Geuns, Evelyn Regar, Bernard De Bruyne, Dariusz Dudek, Leif Thuesen, Bernard Chevalier, Dougal McClean, Stephan Windecker, Robert Whitbourne, Li Dong, Susan Veldhof, Richard Rapoza, Krishnakutty Sudhir, Héctor M. García‐García, John A. Ormiston, Patrick W. Serruys

Journal of the American College of Cardiology

Article2014

Performance of the resolute zotarolimus‐eluting stent in small vessels

Ronald Caputo, Martin B. Leon, Patrick W. Serruys, Franz‐Josef Neumann, Alan C. Yeung, Stephan Windecker, Jorge Belardi, Sigmund Silber, Ian T. Meredith, Petr Widimský, Shigeru Saito, Laura Mauri

Catheterization and Cardiovascular Interventions

Article2013

THE RELATIONSHIP BETWEEN SHORT AND LONG–TERM ANTIPLATELET THERAPY USE AND STENT THROMBOSIS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH THE RESOLUTE ZOTAROLIMUS–ELUTING STENT

Ajay J. Kirtane, Sigmund Silber, Franz‐Josef Neumann, Patrick W. Serruys, Laura Mauri, Ian T. Meredith, Stephan Windecker, Jorge Belardi, Petr Widimský, Alan C. Yeung, Shigeru Saito, Martin B. Leon

Journal of the American College of Cardiology

TCT-639 Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Vessels ≤2.5 mm Diameter

Abstract

Discussion(0)

Related publications

THE RESOLUTE ZOTAROLIMUS-ELUTING STENT IN PATIENTS WIH DIABETES MELLITUS: TWO YEAR OUTCOMES

TCT-137 Five-Year Clinical Outcomes for Resolute Zotarolimus-Eluting Stents in Total Occlusions

SIX MONTH CLINICAL OUTCOMES FOLLOWING THE IMPLANTATION OF THE BIORESORBABLE EVEROLIMUS ELUTING VASCULAR SCAFFOLD IN VESSELS SMALLER OR LARGER THAN 2.5 MM

Performance of the resolute zotarolimus‐eluting stent in small vessels

THE RELATIONSHIP BETWEEN SHORT AND LONG–TERM ANTIPLATELET THERAPY USE AND STENT THROMBOSIS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH THE RESOLUTE ZOTAROLIMUS–ELUTING STENT